Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 118 for “"Neoantigen"”.
-
Improving Neoantigen Prioritization Methods for Personalized Cancer Vaccines
Neoantigens are novel peptide sequences resulting from sources such as somatic mutations in tumors. Upon loading onto major histocompatibility complex (MHC) molecules, they can trigger recognition by T cells. Neoantigen targeting therapies including personalized vaccines have shown promise in the …
-
Investigating Novel Neoantigen Sources for Personalized Cancer Vaccines
… death to tumor cells displaying the antigen. Neoantigens, or tumor-specific peptides, are targeted by cancer immunotherapies to induce T cell-mediated degradation. Treatments such as personalized vaccines and immune checkpoint blockade thus provide a unique avenue to selectively recognize and …
-
Intron Retention Induced Neoantigen as Biomarkers in Diseases
… RNA transcripts can be another major source of neoantigens directly associated with immune responses. Particularly, aberrant peptides derived from unspliced introns can be presented by the major histocompatibility complex (MHC) class I molecules on the cell surface and elicit immunogenicity. In …
-
Characterisation of CD137 as a neoantigen on cancer cells
… the potential role of CD137 as a cancer neoantigen. Using cell lines which overexpress CD137, it was found that CD137 does not protect cancer cells against cell death mediated by lymphokine activated killer cells and chemotherapeutic drugs. Also, CD137-expressing cells do not enhance …
-
Proteogenomic platforms establishing personalized and precision neoantigen therapeutics in cancer
… targets such as mutation-derived antigens (neoantigens), which has accelerated the development of novel immune therapies. Neoantigens are tumour-specific markers that can form when cancer cell-specific mutations encode molecules that differ from ‘self’. Neoantigens may have diverse sources …
-
Identification of the immune signature and neoantigen landscape of myeloproliferative neoplasms
This PhD project has three chapters: <br/><br/>1) Myeloproliferative neoplasms (MPN) are blood cancers characterised by myeloid-derived inflammation and the presence of driver mutations. The somatic mutation JAK2-V617F is present in a large portion of MPN cases. As an onset driver for MPN, …
-
Co-stimulatory Molecules Improve the Immune Response to a Weak Neoantigen
… to deliver tumor specific antigens, termed neoantigens. However, they often do not initiate strong enough CD8+ and CD4+ Type 1 helper (Th1) T cell activation to combat the solid tumors. Thus, it is critical for neoantigen-based cancer vaccines to be delivered with adjuvants to effectively …
-
Cyclin-A1 and neoantigen-specific T cells to target acute myeloid leukaemia
… T cells, we extended the investigations to neoantigens - which arise from mutations in malignant cells and thus represent tumour-exclusive targets. We focussed on 14 recurrent AML driver mutations (including DNMT3AR88X, IDH2R140Q and KRASG12X)) that are collectively present in 40-50% of AML …
-
Neoantigen-Specific T Cells in a Novel Cutaneous Squamous Cell Carcinoma Model
… cSCC murine models that can be used to study neoantigen-specific T cell responses. Outbred SKH-1 mice are highly susceptible to solar UV light-induced cSCC. However, an outbred strain limits the ability to evaluate MHC-restricted, antigen-specific T cell responses and perform studies with …
-
COMPREHENSIVE CHARACTERIZATION OF ALTERNATIVE POLYADENYLATION IN HUMAN CANCERS AND APPLICATIONS IN NEOANTIGEN PREDICTION
… protein isoforms and may serve as a source of neoantigens. Widespread tumor-specific IPA transcripts and neoantigens were observed across cancers. The predicted IPA-derived neoantigens were evidenced to be truly expressed in cancer cells by proteomics data. Importantly, the frequency of …
-
The role of isoform switching and neoantigen formation in the response to radiation
… an altered antigenic landscape with 86 putative neoantigens, and therefore offering insights into novel targeted immunotherapies. The findings propose SRSF1 as a prognostic marker for radiotherapy efficacy in the short-term, and present a foundation for future therapeutic approaches targeting …
-
Isolation of neoantigen-specific T cell receptors for T cell receptor gene therapy
… and specifically mutated antigens, including neoantigens. This increases the number of target antigens for developing precision immunotherapies with high tumor specificity and a favorable safety profile. Challenges in the development include identifying suitable tumor epitopes, isolating …
-
Generation of TGFβR2(-1) neoantigen-specific human T cell receptors from transgenic mice
… to HLA-DRA/DRB1*0401(HLA-DR4). The TGFβR2(-1) neoantigen derives from a frameshift peptide caused by a shift of the open reading frame due to the deletion of one adenine (-1) within a microsatellite sequence. This somatic mutation is frequently expressed in microsatellite instable colorectal …
-
NEOANTIGEN CHARACTERIZATION AS A FUNCTION OF RESPONSE TO PD-1 BLOCKADE IN LUNG CANCER
… We aimed to understand these responses and how neoantigen biochemical properties contribute to T cell reactivity. We developed a bioinformatic platform, Mutation Associated Neoantigen Polarity (MANAPoly), that can analyze genomic data to assess potential biochemical determinants of neoantigen …
-
Mismatch Repair Deficient Neoantigen and Associated Circulating T-Cell Receptor Repertoires in Lynch Syndrome
… develop MMRd tumors with high loads of shared neoantigens (neoAgs), which are recognized by the immune system. Previous research has concentrated on discovering neoAgs and their potential as targets for vaccines in LS patients. However, these studies have primarily identified shared neoAgs from …
-
CoREST complex inhibition alters RNA splicing to promote neoantigen expression and enhance tumor immunity
… splice sites which generate corin-induced splice neoantigens that are demonstrated to be immunogenic in vitro. Corin is further shown to reactivate the response to immune checkpoint blockade and promote dramatic expansion of cytotoxic T cells in an immune cold melanoma tumor model, effectively …
-
High Throughput Computational Methods for Immuno-oncology: Precise Patient Stratification Based on Neoantigen Profile Analyses
Computational prediction of binding between neoantigen peptides and major histocompatibility complex (MHC) proteins can be used to predict patient response to cancer immunotherapy for immune-checkpoint blockade (ICB) therapies. Current neoantigen predictors focus on in silico estimation of MHC …
Page 1 of 6